MARY ESANCY: Open Payments
NPI 1649751975 · BOWLING GREEN, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$503 in 24 payments from 12 companies in 2025. Trend: 2023 $26 · 2024 $984 · 2025 $503
Food & beverage: $503
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $79 |
| Philips North America LLC | 4 | $75 |
| Novartis Pharmaceuticals Corporation | 3 | $70 |
| SCPHARMACEUTICALS INC. | 2 | $57 |
| Amgen Inc. | 3 | $52 |
| PFIZER INC. | 2 | $40 |
| AstraZeneca Pharmaceuticals LP | 2 | $35 |
| Lilly USA, LLC | 1 | $31 |
| Boston Scientific Corporation | 1 | $24 |
| Abbott Laboratories | 1 | $14 |
Products named: Wegovy, FUROSCIX, LEQVIO, Extended Holter, REPATHA, ELIQUIS, LOKELMA, ZEPBOUND.
Industry payments across VA — which companies pay providers there.
